These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 26468990

  • 1. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 2. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G, Wu L, Zheng Q, Jiang X.
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.
    PLoS One; 2018 Dec; 13(9):e0203108. PubMed ID: 30222736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A, Tato M, Broncano-Lavado A, Esteban J, Ruiz-Serrano MJ, Sánchez-Cueto M, Toro C, Domingo D, Cacho J, Barrado L, López-Roa P.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0504122. PubMed ID: 37212700
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients.
    Jayasingam SD, Zin T, Ngeow YF.
    Int J Mycobacteriol; 2017 Jun 15; 6(4):387-390. PubMed ID: 29171453
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F, Loiseau J, Veziris N, Bernard C, Bercot B, Sougakoff W, Jarlier V, Raskine L, Cambau E, French National Reference Center for Mycobacteria.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1669-1677. PubMed ID: 28333340
    [Abstract] [Full Text] [Related]

  • 11. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Rubio A, Wallace RJ.
    Antimicrob Agents Chemother; 2018 Nov 01; 62(11):. PubMed ID: 30126964
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y, Adler A.
    Microb Drug Resist; 2023 Jul 01; 29(7):302-308. PubMed ID: 37219996
    [Abstract] [Full Text] [Related]

  • 13. In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.
    Shen Y, Wang X, Jin J, Wu J, Zhang X, Chen J, Zhang W.
    Biomed Res Int; 2018 Jul 01; 2018():4902941. PubMed ID: 30687747
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ.
    Cornea; 2012 Aug 01; 31(8):900-6. PubMed ID: 22362004
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, Shi ZY.
    J Microbiol Immunol Infect; 2010 Oct 01; 43(5):401-6. PubMed ID: 21075707
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, Wei J, Xia Y, Jiang Y, Zhao X, Liu H, Zhao LL, Liu Z, Xu D, Wan K.
    Int J Antimicrob Agents; 2017 Mar 01; 49(3):364-374. PubMed ID: 28131606
    [Abstract] [Full Text] [Related]

  • 17. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS, Chang SC, Shen EP, Hu FR.
    PLoS One; 2015 Mar 01; 10(1):e0116236. PubMed ID: 25581038
    [Abstract] [Full Text] [Related]

  • 18. Rapidly growing mycobacteria in Singapore, 2006-2011.
    Tang SS, Lye DC, Jureen R, Sng LH, Hsu LY.
    Clin Microbiol Infect; 2015 Mar 01; 21(3):236-41. PubMed ID: 25658536
    [Abstract] [Full Text] [Related]

  • 19. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
    Ceyhan İ, Özkara Ş, Güler MZ, Dulkar G, Altınsoy R, Vezir S.
    Mikrobiyol Bul; 2019 Jul 01; 53(3):330-335. PubMed ID: 31414634
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    J Clin Microbiol; 2017 Jun 01; 55(6):1747-1754. PubMed ID: 28330892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.